MeiraGTx Holdings PLC - ESG Rating & Company Profile powered by AI
The page contains a free E,S&G analysis for MeiraGTx Holdings PLC. Detailed ESG analysis of MeiraGTx Holdings PLC are reached by logging in. If you are employed by MeiraGTx Holdings PLC and you wish to licence your ESG aseessment, please contact us.
MeiraGTx Holdings PLC in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.8; made up of an environmental score of 2.0, social score of 3.2 and governance score of 3.2.
2.8
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1353 | Vera Therapeutics Inc | 2.9 | Medium |
| 1353 | Veracyte Inc | 2.9 | Medium |
| 1393 | MeiraGTx Holdings PLC | 2.8 | Medium |
| 1393 | Bioventix PLC | 2.8 | Medium |
| 1393 | Bolt Biotherapeutics Inc | 2.8 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does MeiraGTx Holdings PLC have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes MeiraGTx Holdings PLC disclose current and historical energy intensity?
Sign up for free to unlockDoes MeiraGTx Holdings PLC report the average age of the workforce?
Sign up for free to unlockDoes MeiraGTx Holdings PLC reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes MeiraGTx Holdings PLC disclose its ethnicity pay gap?
Sign up for free to unlockDoes MeiraGTx Holdings PLC disclose cybersecurity risks?
Sign up for free to unlockDoes MeiraGTx Holdings PLC offer flexible work?
Sign up for free to unlockDoes MeiraGTx Holdings PLC have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes MeiraGTx Holdings PLC disclose the number of employees in R&D functions?
Sign up for free to unlockDoes MeiraGTx Holdings PLC conduct supply chain audits?
Sign up for free to unlockDoes MeiraGTx Holdings PLC disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes MeiraGTx Holdings PLC conduct 360 degree staff reviews?
Sign up for free to unlockDoes MeiraGTx Holdings PLC disclose the individual responsible for D&I?
Sign up for free to unlockDoes MeiraGTx Holdings PLC disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes MeiraGTx Holdings PLC disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes MeiraGTx Holdings PLC disclose water use targets?
Sign up for free to unlockDoes MeiraGTx Holdings PLC have careers partnerships with academic institutions?
Sign up for free to unlockDid MeiraGTx Holdings PLC have a product recall in the last two years?
Sign up for free to unlockDoes MeiraGTx Holdings PLC disclose incidents of discrimination?
Sign up for free to unlockDoes MeiraGTx Holdings PLC allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas MeiraGTx Holdings PLC issued a profit warning in the past 24 months?
Sign up for free to unlockDoes MeiraGTx Holdings PLC disclose parental leave metrics?
Sign up for free to unlockDoes MeiraGTx Holdings PLC disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes MeiraGTx Holdings PLC disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes MeiraGTx Holdings PLC disclose the pay ratio of women to men?
Sign up for free to unlockDoes MeiraGTx Holdings PLC support suppliers with sustainability related research and development?
Sign up for free to unlockDoes MeiraGTx Holdings PLC disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes MeiraGTx Holdings PLC reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs MeiraGTx Holdings PLC involved in embryonic stem cell research?
Sign up for free to unlockDoes MeiraGTx Holdings PLC disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes MeiraGTx Holdings PLC disclose its waste policy?
Sign up for free to unlockDoes MeiraGTx Holdings PLC report according to TCFD requirements?
Sign up for free to unlockDoes MeiraGTx Holdings PLC disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes MeiraGTx Holdings PLC disclose energy use targets?
Sign up for free to unlockDoes MeiraGTx Holdings PLC disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes MeiraGTx Holdings PLC have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for MeiraGTx Holdings PLC
These potential risks are based on the size, segment and geographies of the company.
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative diseases, such as amyotrophic lateral sclerosis; and Parkinson's diseases. Its programs in clinical development include Phase 1/2 clinical stage programs in Achromatopsia, X-Linked Retinitis Pigmentosa, RPE65-deficiency, and radiation-induced Xerostomia, as well as Parkinson's program. The company also focuses on initiating a clinical program in xerostomia related to Sjogren's syndrome and have preclinical programs in neurodegenerative diseases. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. to develop regulatable gene therapy treatment using the company's proprietary riboswitch technology. MeiraGTx Holdings plc was incorporated in 2015 and is based in New York, New York.